106 related articles for article (PubMed ID: 23844986)
1. Analysis of recruitment and outcomes in the phase I/IIa Cethrin clinical trial for acute spinal cord injury.
McKerracher L; Anderson KD
J Neurotrauma; 2013 Nov; 30(21):1795-804. PubMed ID: 23844986
[TBL] [Abstract][Full Text] [Related]
2. A phase I/IIa clinical trial of a recombinant Rho protein antagonist in acute spinal cord injury.
Fehlings MG; Theodore N; Harrop J; Maurais G; Kuntz C; Shaffrey CI; Kwon BK; Chapman J; Yee A; Tighe A; McKerracher L
J Neurotrauma; 2011 May; 28(5):787-96. PubMed ID: 21381984
[TBL] [Abstract][Full Text] [Related]
3. Results of a phase II placebo-controlled randomized trial of minocycline in acute spinal cord injury.
Casha S; Zygun D; McGowan MD; Bains I; Yong VW; Hurlbert RJ
Brain; 2012 Apr; 135(Pt 4):1224-36. PubMed ID: 22505632
[TBL] [Abstract][Full Text] [Related]
4. Rho as a target to promote repair: translation to clinical studies with cethrin.
McKerracher L; Guertin P
Curr Pharm Des; 2013; 19(24):4400-10. PubMed ID: 23360272
[TBL] [Abstract][Full Text] [Related]
5. Rho-ROCK inhibition in the treatment of spinal cord injury.
Forgione N; Fehlings MG
World Neurosurg; 2014; 82(3-4):e535-9. PubMed ID: 23298675
[TBL] [Abstract][Full Text] [Related]
6. Rho Inhibitor VX-210 in Acute Traumatic Subaxial Cervical Spinal Cord Injury: Design of the SPinal Cord Injury Rho INhibition InvestiGation (SPRING) Clinical Trial.
Fehlings MG; Kim KD; Aarabi B; Rizzo M; Bond LM; McKerracher L; Vaccaro AR; Okonkwo DO
J Neurotrauma; 2018 May; 35(9):1049-1056. PubMed ID: 29316845
[TBL] [Abstract][Full Text] [Related]
7. A Randomized Controlled Trial of Local Delivery of a Rho Inhibitor (VX-210) in Patients with Acute Traumatic Cervical Spinal Cord Injury.
Fehlings MG; Chen Y; Aarabi B; Ahmad F; Anderson KD; Dumont T; Fourney DR; Harrop JS; Kim KD; Kwon BK; Lingam HK; Rizzo M; Shih LC; Tsai EC; Vaccaro A; McKerracher L
J Neurotrauma; 2021 Aug; 38(15):2065-2072. PubMed ID: 33559524
[TBL] [Abstract][Full Text] [Related]
8. Multicenter prospective nonrandomized controlled clinical trial to prove neurotherapeutic effects of granulocyte colony-stimulating factor for acute spinal cord injury: analyses of follow-up cases after at least 1 year.
Inada T; Takahashi H; Yamazaki M; Okawa A; Sakuma T; Kato K; Hashimoto M; Hayashi K; Furuya T; Fujiyoshi T; Kawabe J; Mannoji C; Miyashita T; Kadota R; Someya Y; Ikeda O; Hashimoto M; Suda K; Kajino T; Ueda H; Ito Y; Ueta T; Hanaoka H; Takahashi K; Koda M
Spine (Phila Pa 1976); 2014 Feb; 39(3):213-9. PubMed ID: 24299727
[TBL] [Abstract][Full Text] [Related]
9. Spinal cord injury and neural repair: focus on neuroregenerative approaches for spinal cord injury.
Baptiste DC; Tighe A; Fehlings MG
Expert Opin Investig Drugs; 2009 May; 18(5):663-73. PubMed ID: 19379122
[TBL] [Abstract][Full Text] [Related]
10. Timing and duration of anti-alpha4beta1 integrin treatment after spinal cord injury: effect on therapeutic efficacy.
Fleming JC; Bao F; Chen Y; Hamilton EF; Gonzalez-Lara LE; Foster PJ; Weaver LC
J Neurosurg Spine; 2009 Nov; 11(5):575-87. PubMed ID: 19929361
[TBL] [Abstract][Full Text] [Related]
11. Acidic fibroblast growth factor for repair of human spinal cord injury: a clinical trial.
Wu JC; Huang WC; Chen YC; Tu TH; Tsai YA; Huang SF; Huang HC; Cheng H
J Neurosurg Spine; 2011 Sep; 15(3):216-27. PubMed ID: 21663406
[TBL] [Abstract][Full Text] [Related]
12. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study.
Bracken MB; Shepard MJ; Collins WF; Holford TR; Young W; Baskin DS; Eisenberg HM; Flamm E; Leo-Summers L; Maroon J
N Engl J Med; 1990 May; 322(20):1405-11. PubMed ID: 2278545
[TBL] [Abstract][Full Text] [Related]
13. Oscillating field stimulation for complete spinal cord injury in humans: a phase 1 trial.
Shapiro S; Borgens R; Pascuzzi R; Roos K; Groff M; Purvines S; Rodgers RB; Hagy S; Nelson P
J Neurosurg Spine; 2005 Jan; 2(1):3-10. PubMed ID: 15658119
[TBL] [Abstract][Full Text] [Related]
14. Comparison of neurological and functional outcomes after administration of granulocyte-colony-stimulating factor in motor-complete versus motor-incomplete postrehabilitated, chronic spinal cord injuries: a phase I/II study.
Saberi H; Derakhshanrad N; Yekaninejad MS
Cell Transplant; 2014; 23 Suppl 1():S19-23. PubMed ID: 25302604
[TBL] [Abstract][Full Text] [Related]
15. (-)-Epigallocatechin-3-gallate (EGCG) modulates neurological function when intravenously infused in acute and, chronically injured spinal cord of adult rats.
Renno WM; Al-Khaledi G; Mousa A; Karam SM; Abul H; Asfar S
Neuropharmacology; 2014 Feb; 77():100-19. PubMed ID: 24071567
[TBL] [Abstract][Full Text] [Related]
16. Characterization of neurological recovery following traumatic sensorimotor complete thoracic spinal cord injury.
Zariffa J; Kramer JL; Fawcett JW; Lammertse DP; Blight AR; Guest J; Jones L; Burns S; Schubert M; Bolliger M; Curt A; Steeves JD
Spinal Cord; 2011 Mar; 49(3):463-71. PubMed ID: 20938451
[TBL] [Abstract][Full Text] [Related]
17. Effect of 17beta-estradiol on functional outcome, release of cytokines, astrocyte reactivity and inflammatory spreading after spinal cord injury in male rats.
Ritz MF; Hausmann ON
Brain Res; 2008 Apr; 1203():177-88. PubMed ID: 18316064
[TBL] [Abstract][Full Text] [Related]
18. FTY720 improves functional recovery after spinal cord injury by primarily nonimmunomodulatory mechanisms.
Norimatsu Y; Ohmori T; Kimura A; Madoiwa S; Mimuro J; Seichi A; Yatomi Y; Hoshino Y; Sakata Y
Am J Pathol; 2012 Apr; 180(4):1625-35. PubMed ID: 22417787
[TBL] [Abstract][Full Text] [Related]
19. Clinical experience using incubated autologous macrophages as a treatment for complete spinal cord injury: phase I study results.
Knoller N; Auerbach G; Fulga V; Zelig G; Attias J; Bakimer R; Marder JB; Yoles E; Belkin M; Schwartz M; Hadani M
J Neurosurg Spine; 2005 Sep; 3(3):173-81. PubMed ID: 16235699
[TBL] [Abstract][Full Text] [Related]
20. Secondary injury mechanisms in acute spinal cord injury.
Young W
J Emerg Med; 1993; 11 Suppl 1():13-22. PubMed ID: 8445198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
